<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><description>🔬 Leveraging cutting-edge AI-driven protein design technologies to deliver custom, high-quality affinity reagents at unprecedented speed ⚡🧬&#xA;</description><link>https://bsky.app/profile/affinityaibio.bsky.social</link><title>@affinityaibio.bsky.social - AffinityAI</title><item><link>https://bsky.app/profile/affinityaibio.bsky.social/post/3m2ts7o42ak2j</link><description>🐍 Our Nature paper shows AI-designed proteins can save lives.&#xA;&#xA;De novo binders that neutralise deadly snake venom — no antibodies, no immunisation.&#xA;&#xA;Mice survived lethal doses. This is what generative design can do.&#xA;&#xA;👉 Get in touch: affinityai.dk</description><pubDate>10 Oct 2025 13:39 +0000</pubDate><guid isPermaLink="false">at://did:plc:uqrfzdclyo5dv3ej3vorbnwi/app.bsky.feed.post/3m2ts7o42ak2j</guid></item><item><link>https://bsky.app/profile/affinityaibio.bsky.social/post/3lyik4445z22t</link><description>🚀AffinityAI has joined the @scaleway.com Growth Stage Startup Program!&#xA;&#xA;This means more GPU power → faster #AI-#designed #protein #binders🧬💻&#xA;Grateful to Scaleway for supporting our mission to accelerate biotech innovation🌍⚡&#xA;Onward to faster protein design + impactful discoveries!</description><pubDate>10 Sep 2025 15:24 +0000</pubDate><guid isPermaLink="false">at://did:plc:uqrfzdclyo5dv3ej3vorbnwi/app.bsky.feed.post/3lyik4445z22t</guid></item><item><link>https://bsky.app/profile/affinityaibio.bsky.social/post/3lxwosqyjjs2v</link><description>🤝 Excited to announce our partnership with LenioBio to accelerate de novo protein discovery.&#xA;&#xA;By combining our Designerbodies™ with LenioBio’s ALiCE® cell-free system, we can go from design to test with unprecedented speed.&#xA;&#xA;Full announcement: https://www.affinityai.dk/news-affinityai-leniobio</description><pubDate>03 Sep 2025 13:00 +0000</pubDate><guid isPermaLink="false">at://did:plc:uqrfzdclyo5dv3ej3vorbnwi/app.bsky.feed.post/3lxwosqyjjs2v</guid></item><item><link>https://bsky.app/profile/affinityaibio.bsky.social/post/3lww46kqv4227</link><description>👏 Big congrats to Max Overath, our CEO @tpjenkins.bsky.social, our CAIO Oliver Morell &amp; collaborators on their new preprint on filtering de novo designed binders for in vitro success.&#xA;&#xA;📄 https://www.biorxiv.org/content/10.1101/2024.08.20.555600v1</description><pubDate>21 Aug 2025 14:02 +0000</pubDate><guid isPermaLink="false">at://did:plc:uqrfzdclyo5dv3ej3vorbnwi/app.bsky.feed.post/3lww46kqv4227</guid></item><item><link>https://bsky.app/profile/affinityaibio.bsky.social/post/3lu2znmvktk25</link><description>Whether you&#39;re on holiday 🏖️ or still in the lab 🧪 trying to keep cool, at least one thing isn&#39;t melting: our DesignerBodies.&#xA;&#xA;Generatively designed. Thermally stable ❄️ Reliable reagents that don’t need a break 💪&#xA;&#xA;#ProteinDesign #AI #Biotech</description><pubDate>16 Jul 2025 08:44 +0000</pubDate><guid isPermaLink="false">at://did:plc:uqrfzdclyo5dv3ej3vorbnwi/app.bsky.feed.post/3lu2znmvktk25</guid></item><item><link>https://bsky.app/profile/affinityaibio.bsky.social/post/3lrcuyi2auk2y</link><description>We’re rethinking what a binding reagent can be.&#xA;&#xA;Most antibodies weren’t designed, they were discovered. At AffinityAI, we’re flipping that logic: we build binders from first principles, guided by generative AI.&#xA;&#xA;What targets would you be interested in having a binder to?</description><pubDate>11 Jun 2025 07:26 +0000</pubDate><guid isPermaLink="false">at://did:plc:uqrfzdclyo5dv3ej3vorbnwi/app.bsky.feed.post/3lrcuyi2auk2y</guid></item><item><link>https://bsky.app/profile/affinityaibio.bsky.social/post/3lqmw6pgbc22y</link><description>Ægget redefined the lounge.&#xA;We&#39;re redefining what it means to design a protein.&#xA;&#xA;At AffinityAI, we combine Danish design sensibilities with precision molecular engineering. Elegant. Efficient. Engineered to bind.&#xA;&#xA;🧬 Discover how we’re reshaping molecular function:&#xA;&#xA; www.affinityai.bio</description><pubDate>02 Jun 2025 13:49 +0000</pubDate><guid isPermaLink="false">at://did:plc:uqrfzdclyo5dv3ej3vorbnwi/app.bsky.feed.post/3lqmw6pgbc22y</guid></item><item><link>https://bsky.app/profile/affinityaibio.bsky.social/post/3lppgmj7mns2b</link><description>AffinityAI was at PEGS Boston last week, where our CEO @tpjenkins.bsky.social joined to speak with researchers and industry colleagues about advances in generative binder design, automation, and our DesignerBodies™. 🧬🤖&#xA;&#xA;Plenty of great conversations and some promising leads🧪</description><pubDate>21 May 2025 20:23 +0000</pubDate><guid isPermaLink="false">at://did:plc:uqrfzdclyo5dv3ej3vorbnwi/app.bsky.feed.post/3lppgmj7mns2b</guid></item><item><link>https://bsky.app/profile/affinityaibio.bsky.social/post/3lpbwod4cr22u</link><description>Great energy at DTU Startup Day 🎉&#xA;Big thanks to @DTUSkylab for bringing together researchers, investors, and innovators.&#xA;We had a blast sharing what we&#39;re building at AffinityAI.&#xA;&#xA;#AffinityAI #DTUSkylab #StartupLife</description><pubDate>16 May 2025 11:34 +0000</pubDate><guid isPermaLink="false">at://did:plc:uqrfzdclyo5dv3ej3vorbnwi/app.bsky.feed.post/3lpbwod4cr22u</guid></item><item><link>https://bsky.app/profile/affinityaibio.bsky.social/post/3lonvx2ftw22b</link><description>🚀 AffinityAI is live&#xA;We&#39;re delivering custom protein binders designed with AI + validated in vitro — fast, precise, and animal-free.&#xA;Perfect for research, diagnostics, and therapeutics.&#xA;🔗 affinityai.org&#xA;&#xA;#AffinityAI #ProteinDesign #SyntheticBiology</description><pubDate>08 May 2025 12:27 +0000</pubDate><guid isPermaLink="false">at://did:plc:uqrfzdclyo5dv3ej3vorbnwi/app.bsky.feed.post/3lonvx2ftw22b</guid></item></channel></rss>